Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Visit
Dr Ruben A. Mesa discusses the design of the upcoming PERSIST- 2, and other related trials of pacritinib.